When medicinal cannabis causes harm in vulnerable patients
Potential Iatrogenic Harms From Medicinal Cannabis Prescribing in Australia: A Case Series.
AI Summary
This case series describes three young men aged 20–24 in Australia who had psychiatric conditions and vulnerabilities related to substance use before receiving medicinal cannabis. The reported harms included cannabinoid hyperemesis syndrome, cannabis use disorder, paranoia, mood instability, and delays in receiving other treatments. The paper does not estimate how often these problems occur; instead, it uses individual cases to illustrate possible risks.
The cases also raise concerns about prescribing practices. In two cases, medicinal cannabis prescribing continued despite worsening problems or a formal request from an addiction specialist to stop. The authors call for more evidence-based prescribing, clearer criteria for excluding high-risk patients, and faster discontinuation when harms appear. For users with psychiatric or addiction vulnerabilities, the findings emphasize the importance of careful monitoring and prompt review if cannabis worsens symptoms or creates new problems.
💡 Key Findings
📄
Original Abstract
Related Research
Similar Studies
More THC research papers you might find interesting.
Small lab study finds cannabis affected simulated driving and confidence
A lab method measures 17 cannabinoids across five hemp product types
A single-center study finds varied care and no recurrence in follow-up
Explore More Research
Stay informed about the latest cannabis science.